RxDoctor Payments Data

Donald Nichols, DPM

Podiatrist · Clayton, GANPI 1871560235

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Fusion Orthopedics USA, LLC at 59.7% of the total. Reporting peaked in 2024 at $2,576 and has fallen 78.8% since, to $546 in 2025.

$6,618in general payments, 2019–2025

Across 57 payments — averaging $116.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fusion Orthopedics USA, LLC$4K
  • Paragon 28, Inc.$656
  • Bone Support Inc.$435
  • Stryker$336
  • Treace Medical Concepts, Inc.$256
  • Smith+Nephew$186
  • plus $796 from 21 others

What the payments were for

  • Consulting fees$1,00015%
  • Travel & lodging$3,04646%
  • Food & beverage$2,44937%
  • Education$561%
  • Gifts$110%
  • Entertainment$561%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,618 in reported general payments places this provider in the 80th percentile of 177 podiatrist providers in Georgia.

See all podiatrist providers in Georgia

Medicare billing

Part B allowed, 2024
$124,243
Medicare patients
362
Services billed
1,503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin117$2,961
Terbinafine Hcl52$1,147
Ketoconazole48$867
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$249
Naproxen44$212
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$193
Clindamycin Hcl12$120
Meloxicam45$57

Paid to pharmacies, not to this prescriber.

Other podiatrist in Clayton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →